Kok, Chung H. http://orcid.org/0000-0002-3181-7852
Saunders, Verity A.
Dang, Phuong
Shanmuganathan, Naranie http://orcid.org/0000-0001-5895-8797
White, Deborah http://orcid.org/0000-0003-4844-333X
Branford, Susan
Yeung, David
Hughes, Timothy P. http://orcid.org/0000-0002-0910-3730
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1135949, APP1117718, APP1138935, APP1027531)
Cancer Council South Australia (N/A, N/A)
Article History
Received: 6 July 2023
Revised: 18 August 2023
Accepted: 30 August 2023
First Online: 11 September 2023
Competing interests
: NS received research funding from Novartis and honoraria from Takeda. SB is a member of the advisory boards of Qiagen and Cepheid, received honoraria from Qiagen, Novartis, and Cepheid, and research funding from Novartis and Cepheid. DY received research funding from Novartis and BMS; and received honoraria from Novartis, Takeda, Pfizer and Amgen. TPH received research funding from Novartis and BMS and honoraria from Novartis, BMS, and Takeda. The remaining authors have no conflict of interest to disclose.